Evidence map›Paper›PMID 38026479›Full record

ArticleFrontiers in surgery2023

Minimally invasive surgery for placement of a subcutaneous EEG implant.

Bjarki D Djurhuus, Pedro F Viana, Esben Ahrens, Sofie S Nielsen, Harishchandra L Srinivasan, Mark P Richardson, Preben Homøe, Harutomo Hasegawa, Ali A Zarei, Pia L K Gauger and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Bjarki D DjurhuusDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, University of Copenhagen, Koge, Denmark.
Pedro F VianaSchool of Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Esben AhrensDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Sofie S NielsenUNEEG medical, Alleroed, Denmark.
Harishchandra L SrinivasanNeurosurgery Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Mark P RichardsonSchool of Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Preben HomøeDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, University of Copenhagen, Koge, Denmark.
Harutomo HasegawaNeurosurgery Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Ali A ZareiUNEEG medical, Alleroed, Denmark.
Pia L K GaugerUNEEG medical, Alleroed, Denmark.
Jonas Duun-HenriksenUNEEG medical, Alleroed, Denmark.
King's College Hospital NHS Foundation Trust · GBKing's College London · GBZealand University Hospital Køge · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A new class of subcutaneous electroencephalography has enabled ultra long-term monitoring of people with epilepsy. The objective of this paper is to describe surgeons' experiences in an early series of implantations as well as discomfort or complications experienced by the participants. Methods: We included 38 implantation procedures from two trials on people with epilepsy and healthy adults. Questionnaires to assess surgeons' and participants' experience were analyzed as well as all recorded adverse events occurring up to 21 days post-surgery. Results: With training, the implantation could be performed in approximately 15 min. Overall, the implantation procedure was considered easy to perform with only 2 episodes where the implant got fixated in the introducing needle and a new implant had to be used. The explantation procedure was considered effortless. In 2 cases the silicone sheath covering the lead was damaged during the explantation, but it was possible to remove the entire implant without leaving any foreign body under the skin. Especially in the trial on healthy participants, a proportion experienced adverse events in the form of headache or implant-pain up to 21 days post-operatively. In 6 cases, adverse events contributed to the decision to explant and discontinue the study: Four of these cases involved implant pain or headache; One case involved a post-operative local infection; and in one case superficial lead placement resulted in skin perforation a few weeks after implantation. Conclusion: The implantation and explantation procedures are considered swift and easy to perform by both neurosurgeons and ENT surgeons. The implant is well tolerated by most participants. However, headache or pain around the implant can occur for up to 21 days post-operatively as anticipated with any such surgery. The expected benefits from the implant should always outweigh the potential disadvantages.

Indexed as

epilepsyminimally-invasive surgerysubcutaneous EEGsub-scalpultra long-term monitoring

Identifiers

PMID38026479
PMCPMC10665563
OpenAlexW4388616049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.